RETA
Reata Pharmaceuticals Inc
Chief Commercial Officer Dawn Carter Bir sold $8.5M of Reata Pharmaceuticals Inc
Sold$8,503,621
$87.67Price
96,996Shares
−70%Stake
What RETA did after the filing
- The stock from Wed, Mar 8 close, $83.96
- +18.9%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Apr 20 close.
Traded Mon, Mar 6. Filed Wed, Mar 8, 12:17 PM ET, during the session. Returns use the Mar 8 close and the Apr 20 close. Not investment advice.